Biomonitoring of chromium(VI) deposited in pulmonary tissues: Pilot studies of a magnetic resonance imaging technique in a post-mortem rodent model

Biomarkers

Volumn 9, Issue 1, 2004, Pages 32-46

  Shayer, Rob ^a   Kinchesh, Paul ^b   Raffray, Mark ^a   Kortenkamp, Andreas ^c  

^a Tobacco Policy Team ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chromate; Chromium(VI); Lung; Magnetic resonance imaging

Indexed keywords

BIOLOGICAL MARKER; CHROMIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CADAVER; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; LUNG PARENCHYMA; LUNG TOXICITY; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; QUANTITATIVE ANALYSIS; RAT; RODENT; SPECTROMETER; TISSUE LEVEL;

ANIMALS; BIOLOGICAL MARKERS; CHROMIUM; DENSITOMETRY; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; LUNG; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; RATS; RATS, WISTAR; TIME FACTORS;

RODENTIA;

EID: 2442671760     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13547500310001659037     Document Type: Article

References (25)

1. ACGIH. 1999, TLVs® and BEI®. Cincinnati: American Conference of Governmental Industrial Hygienists. Cincinnati, USA
2. Barnhart, J. L. and Berk, R. N. 1986, Influence of paramagnetic ions and pH on proton NMR relaxation of biologic fluids. Investigative Radiology, 21, 132-136.
3. Bergin, C. J., Glover, G. M. and Pauly, J. 1993, Magnetic resonance imaging of the lung parenchyma. Journal of Thoracic Imaging, 8, 12-17.
4. Brauer, M. 1993, Magnetic resonance imaging and spectroscopy: new noninvasive in vivo approaches in toxicology research. Alternatives to Laboratory Animals, 21, 411-425.
5. Casadevall, M. and Kortenkamp, A. 2002, Chromium and cancer. In Heavy Metals in the Environment, edited by B. Sarkar (New York, Basel: Marcel Dekker New York), pp. 271-308.
6. De Flora, S. and Wetterhahn, K. E. 1989, Mechanisms of chromium metabolism and genotoxicity. Life Chemistry Reports, 7, 169-244.
7. Deseran, M. W., Colletti, P. M., Ratto, D., Ansari, A. and Siegel, M. E. 1988, Chronic berylliosis. Demonstration by gallium-67 imaging and magnetic resonance imaging. Clinical Nuclear Medicine, 13, 509-511.
8. DFG (Deutsche Forschungsgemeinschaft). 1999, List of MAK and BAT Values 1999, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Report No. 35. Weinheim: Wiley-VCH.
9. Golman, K., Klaveness, J., Holtz, E., Leunbach, I., Rye, A. S. and Almen, T. 1988, A magnetic resonance imaging contrast medium for the liver and bile. Investigative Radiology, 23 (Supplement 1), 243-245.
10. Greger, J. L. 1999, Nutrition versus toxicology of manganese in humans: evaluation of potential biomarkers. Neurotoxicology, 20, 205-212.
11. Hyodo, K., Suzuki, S., Furuya, N. and Meshizuka, K. 1980, An analysis of chromium, copper and zinc in organs of a chromate worker. International Archives of Occupational and Environmental Health, 46, 141-150.
12. IARC. 1990, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 49, Chromium, Nickel and Welding (Lyon: International Agency for Research on Cancer).
13. Kalliomäki, K., Aittoniemi, K., Kalliomäki, P.-L. and Moilanen, M. 1981, Measurement of lung-retained contaminants in vivo amongst workers exposed to metal aerosols. American Industrial Hygiene Association Journal, 42, 234-238.
14. Kishi, R., Tarumi, T., Uchino, E. and Miyake, H. 1987, Chromium content of organs of chromate workers with lung cancer. American Journal of Industrial Medicine, 11, 67-74.
15. Kortenkamp, A. 1997, Problems in the biological monitoring of chromium(VI) exposed individuals. Biomarkers, 2, 73-80.
16. Kortenkamp, A., Casadevall, M., Da Cruz Fresco, P. and Shayer, R. O. J. 1997, Pathways in the chromium(VI)-mediated formation of DNA lesions: a review. NATO ASI Series, 2, 15-34.
17. Leonard, A. and Bernard, A. 1993, Biomonitoring exposure to metal compounds with carcinogenic properties. Environmental Health Perspectives, 101 (Supplement 3), 127-133.
18. Liu, K. J., Shi, X. and Dalai, N. S. 1997, Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity. Biochemical and Biophysical Research Communications, 235, 54-58.
19. O'Brien, P., Barrett, J. and Swanson, F. 1985, Chromium(V) can be generated in the reduction of chromium(VI) by glutathione. Inorganica Chimica Acta, 108, L19.
20. Singh, J., Prithchard, D. E., Carlisle, D. L., Mclean, J. A., Montaser, A., Orenstein, J. M. and Patierno, S. R. 1999, Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicology and Applied Pharmacology, 161, 240-248.
21. Slade, R., Crissman, K., Norwood, J. and Hatch, G. 1993, Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. Experimental Lung Research, 19, 469-484.
22. Standeven, A. M. and Wetterhahn, K. E. 1992, Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis, 13, 1319-1324.
23. Sugiyama, M. 1994, Role of paramagnetic chromium in chromium (VI)-induced damage in cultured mammalian cells. Environmental Health Perspectives, 102 (Supplement 3), 31-33.
24. Tsuneta, Y., Ohsaki, Y., Kimura, K., Mikami, H., Abe, S. and Murao, M. 1980, Chromium content of lungs of chromate workers with lung cancer. Thorax, 35, 294-297.
25. Ueno, S., Susa, N., Furukawa, Y. and Sugiyama, M. 1995, Formation of paramagnetic chromium in liver of mice treated with dichromate(VI). Toxicology and Applied Pharmacology, 135, 165-171.